The Steinbeis-Europa-Zentrum receives funding to build a network for "Bio-active plant ingredients” in Baden-Wuerttemberg from the "Central Innovation programme SME - ZIM" under the funding module NEMO of the Federal Ministry of Economics and Technology. BIOPRO Baden-Wuerttemberg GmbH supports the network as one of the partners.
BIOPRO Baden-Württembergs business development activities have led to the establishment of a new distribution partnership between Heidelberg-based Medicyte GmbH and Dutch Westburg BV. When BIOPRO searches for international partners for Baden-Württemberg companies the state agency often makes use of its international network partners and in this case BIOPROs contact with the Netherlands Business Support Office Stuttgart NBSO brought the desired results.
Dietary supplements support a well-balanced diet and lifestyle. Anoxymer GmbH develops health-enhancing plant extracts that contribute to healthy nutrition. With its expertise in using raw materials from South America for the development of botanical extracts and the distribution of its products in Asia, the company is a competent partner in the “Bioactive Plant Foods” network.
VivaCell Biotechnology GmbH offers in vivo and in vitro demonstration of the efficacy of pharmaceutical and phytopharmaceutical compounds and nutraceuticals. Using its specific in vitro and in vivo models, the company has been able to prove the health-enhancing effect of numerous foods, and is thus an excellent partner in the Bioactive Plant Foods Network.
It is also in the interest of small companies to look beyond their national borders: biotechnology and medical technology specialists in neighbouring European countries offer excellent prospects to German companies – and vice versa. Regional life sciences networks help establish and intensify contacts and collaborative activities between international partners.
The Bioactive Plant Foods network which is coordinated by the Steinbeis-Europa-Zentrum in Stuttgart is focused on developing innovative products that have a positive effect on human health and placing them on the market. Research resolves around the health-promoting effect of amaranth a short-lived plant with catkin-like cymes of densely packed red flowers. More than 20 partners from industry science and marketing have been working together since 2010 to advance the issue of biological activity and health. The coordinator of the network Hartmut Welck provides insights into this sector in Baden-Württemberg the successes that have been achieved by network partners and why the network is particularly focussing on amaranth.
A European network for research into rare inherited metabolic disorders will be coordinated by PD Dr. Stefan Kölker, head of the Division of Inherited Metabolic Diseases at the Centre for Paediatric and Adolescent Medicine, University of Heidelberg. The project, which will initially run for three years, has a financial volume of 1.3 million euros. More than 40 partners from 17 European countries are part of the “European registry and network for intoxication type metabolic diseases (E-IMD)”.
BioRegio STERN Management GmbH has honoured the winning projects in the regional “Science2Start” competition. A panel of experts awarded a total of 2,250 euros for the most innovative ideas with marketing potential. The winners celebrated their success with approx. 240 visitors of the annual summer event jointly organised by BioRegio STERN Management GmbH, the Society for the Promotion of Biotechnology Stuttgart/Tübingen/Neckar-Alb e.V. and PUSH! e.V., a partner network for new companies founded by academics at Stuttgart universities
The gastrointestinal tract and its nervous system have numerous functions related to the uptake of food and they also play an important role in the development of adiposity. The Institute of Nutritional Medicine at the University of Hohenheim Germany carries out numerous projects aimed at investigating the relationships between food uptake digestive and nervous systems thus making the institute an excellent partner in the Bioactive Plant Foods network.
BioRegio STERN Management GmbH honoured the winners of the regional “Science2Start” ideas competition on July 21. The three victors from Stuttgart, Tübingen and Reutlingen celebrated their success together with over 300 guests at a joint summer reception organised by BioRegio STERN Management GmbH, PUSH! (the partner network for new companies founded by academics at Stuttgart universities), the Society for the Promotion of Biotechnology and Medical Technology and the University of Hohenheim.
Ten years ago, cellular signalling was a simple and straightforward process. Nowadays, what once seemed so simple is riddled with complexities. Dr. Tilman Brummer and his team at the Centre for Biosystems Analysis (ZBSA) in Freiburg are investigating the complex molecular interactions sparked off by signals inside cells. They are especially interested in the signalling network involving the protein Raf. Faults in the dynamic processes involving the molecule and its numerous interaction partners can lead to cancer. The researchers can only effectively intervene if they know and understand the entire network.
The process of ageing appears, at least at first sight, to be fairly tangible and is visible both at individual and societal level. Nevertheless, science has not yet come up with detailed insights into the physiology of ageing. Jörg Bergemann, Professor of Biomedical Engineering at the Albstadt-Sigmaringen University of Applied Sciences, is studying the processes of ageing in skin cells in a project that has recently been granted funding by the German Federal Ministry of Education and Research (BMBF). Bergemann almost missed the BMBF’s deadline when one project partner unexpectedly backed out of the project. However, the BioLAGO network stepped in at the last minute to help.
AnDiaTec GmbH & Co. KG from Kornwestheim is in high demand worldwide as a partner specialising in detection methods for bacteria and viruses. The company is a world market leader in real time PCR Kits for the detection of noroviruses. The U.S. Ministry of Agriculture even draws on the expertise of AnDiaTec in relation to virus infections in cattle. After an intensive period of research and development, the company is now expanding its sales network even further. The first contracts have already been signed with pharmaceutical groups.
BioRegio STERN Management GmbH is one of five project partners in BIOMAT-In. This transnational EU project promotes innovations and cooperation in the biomaterials sector and is being funded for three years with a total of EUR 1.24 million. BioRegio STERN Management GmbH is committed to creating a successful pan-European cluster in regenerative medicine and tissue engineering. It is receiving EUR 223,000 during this period to develop a sustainable network of companies, institutions and hospitals.
The objective of the National Cohort study, the largest prospective study ever conducted in Germany, is to provide answers to a broad range of epidemiological questions, to identify risk factors for common diseases and to open up new treatment pathways. This project is being planned since beginning 2009 by the health centers of the Helmholtz Association in a network with partners from universities and other public research institutions.
“capmatch medical” was specifically designed for young medical device and biotech companies that are seeking capital from investors in Europe. Combined with professional coaching and process management, capmatch medical’s matching approach improves the chances of successful matchmaking between companies and dedicated investors.
European Commission Vice President Günter Verheugen launched Enterprise Europe Network a new and powerful European support network for enterprises. All major players of the business support community in Europe have united to offer a one-stop service to assist especially small and medium sized enterprises.
Bioactive substances are the speciality of BioTeSys GmbH an Esslingen-based biotech company. The company works with a range of products including cosmetics plant and berry extracts and low-dosage non-prescription food supplements. BioTeSys investigates the efficacy of the active ingredients of such products as well as the raw materials used to manufacture them.
Under the working title of "EuroPro+MeD", which stands for European Prosthesis + Medical Devices, BioRegio STERN Management GmbH, Germany, Pôle Technologique de Haute-Champagne, (PTHC) France and the Medical Cluster, Switzerland have signed a strategic partnering agreement to boost joint cross-border cooperation projects between their respective companies and research institutes in the field of medical technology. The partnership was made official on 24 September 2009 under the patronage of Luc Chatel, the French Minister of National Education during the international "PROSTHESIA" conference which took place in Nogent, France.
“In order to fully understand an organism, it is necessary to consider it as a whole,” said Dr. Uwe Schulte, biochemist and CEO of Logopharm GmbH in Freiburg. A growing number of scientists hold the same view, and there is a growing inclination to research the big picture. This is reflected in the continuously increasing number of projects looking into systems biology research.
The German Cancer Research Centre and Bayer Schering Pharma AG signed an agreement to establish a strategic research alliance. The partners will invest a total of 3.5 million euros in cooperative cancer research over the next two years.
As the proper function of the network of nerve cells in our brain depends on the kind of contacts between the individual neurons Professor Peter Jonas from the Institute of Physiology I at the University of Freiburg is investigating processes that occur at these contact sites - i.e. the synapses.
Prof. Michael Berthold has an ideal colleague in mind this person has been with the company for decades knows everybody has read every important document has seen all the experiments and talked to everybody. This ideal colleague is actually a projected software system.
VC-BW a joint project run by the Baden-Württemberg Ministry of Finances and Economics and Stuttgart Financial is aimed at creating a common platform for existing business angel networks VC forums business development banks and VC companies. The overall goal of VC-BW is to make Baden-Württemberg more visible and attractive for investors from outside Baden-Württemberg. In addition it will give start-up companies easier access to higher investment volumes of between 300000 and 3 million euros. Interested parties are invited to submit their one-page representations to BIOPRO by 6th December 2012. The next pitch will be held on 13th January 2013.